Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + S-amlodipine (CKD-828) versus telmisartan in inadequately controlled hypertension
KCT0000318Phase 3Completed
- Sponsor
- Chong Kun Dang
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing CKD-828 (telmisartan + S-amlodipine) with Telmisartan monotherapy (2 arms). Started Aug 2011; status: completed.
02
Drugs
telmisartanLevamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on KCT0000318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000318.